002422:SZSESichuan Kelun Pharmaceutical Co., Ltd. Analysis

Sichuan Kelun Pharmaceutical is trading in a bullish technical environment, with the 20‑day SMA comfortably above both the 50‑day and 200‑day averages and a MACD histogram in positive territory. RSI around the low‑sixties supports continued upside without being overbought, while price sits just below a clear resistance near the recent high. Fundamentally, the stock appears stretched – the trailing P/E is well above the industry average and the discounted cash‑flow model suggests a fair value far lower than the current market price. The company enjoys a strong cash buffer and modest leverage, enabling a dividend yield of roughly 1.6% with a payout ratio near two‑thirds, though earnings growth remains modest. Overall, the blend of bullish momentum, high valuation, and solid balance‑sheet fundamentals creates a nuanced outlook that varies by investment horizon.